I have watched Boston Scientific (BSX) for quite some time. Today, I am adding BSX to the IA portfolio with a buy limit of $25.

The BSX insiders have an excellent track record, and their timing on purchases and sells are usually accurate. After my February 16, 2006 post, “Big Move in BSX", insiders at BSX have continued to accumulate shares even at current levels. This is the reason I wanted to add BSX to the portfolio now.

To make room for BSX, I am selling United Healthcare (UNH). UNH has rewarded us handsomely since we bought it pre-split in November 2004. After the 2-1 split, our adjusted cost basis is $41, giving us a 17.60 point gain for a return of 43%.

In addition, I am not happy with the price action in Oracle (ORCL). We are also selling ORCL from the IA portfolio.